Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
Madgula A, Covello B, Singh M, Rao A, Lee J. Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease. Cureus 2020, 12: e7215. PMID: 32274273, PMCID: PMC7141794, DOI: 10.7759/cureus.7215.Peer-Reviewed Original ResearchInterstitial lung diseaseLung diseaseTreatment of interstitial lung diseaseAdvent of immunotherapyAcquired immunodeficiency syndromeTyrosine kinase inhibitorsGrowth factor receptorSmall-sized studiesShortness of breathFibroblast growth factor receptorImmunodeficiency syndromeClinical presentationDormant infectionTalaromycosisFactor receptorFungal infectionsKinase inhibitorsRespiratory symptomsTreat several conditionsEndemic regionsNintedanibPatientsInfectionDiseaseImmunotherapy